Healthcare
GMED Stock Analysis
Globus Medical, Inc. · current price $83.06 (+0.56% today)
Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★
Quality
GMED Stock AnalysisGlobus Medical, Inc. · current price $83.06 (+0.56% today)
Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.
Reading GMED’s price and volume history…
Checking the areas that decide this thesis…
AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.
Reading GMED’s filings…
| Quarter | EPS | Est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-30 | $1.18 | $0.78 | +51.1% | Beat |
| 2025-12-31 | $1.28 | $1.15 | +11.0% | Beat |
| 2026-03-31 | $1.12 | $0.92 | +21.7% | Beat |
| 2026-06-30 | $1.34 | $1.10 | +21.9% | Beat |
Globus Medical, Inc. (GMED) currently has a TickerMover Quant Score of 62/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.
TickerMover does not give buy or sell recommendations. GMED scores 62/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.
GMED's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.
Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.
Open the dashboard for GMED →
